Medical Imaging Market Size | Growth, Share, Demand, Industry Analysis, Key Player profile and Regional Outlook by 2027

 

Market Highlights

Market Research Future (MRFR) assessed the global medical imaging market 2020 through the review period till 2025. MRFR study states that the medical imaging market is expected to rise at 6.52% CAGR across the forecast period. By 2025, the medical imaging market value can touch USD 45,719.65 Mn. Technological advancements in healthcare applications and strategic agreements among top-notch tech companies and medical service providing giants are causes that are expected to support expansion of the medical imaging market in the years ahead. Improvements in point-of-care in case of ultrasound systems, easy portability of magnetoencephalography (MEG) brain scanners, and other revolutionizing trends in the diagnostic sector are anticipated to contribute to the improving impetus of the medical imaging market.   Medical imaging solution providers are investing in innovations designed to offer accurate imaging solutions at affordable price. This is expected to create lucrative scope for the new players in the medical imaging market. However, surge in cost of diagnostic image solutions and inability of healthcare organizations to purchase expensive imaging systems due to economic disruption induced by COVID 19 pandemic can hinder the medical imaging market rise.

                                                               

Segment Analysis

The segment study of the global medical imaging market are modality, end-user, and application. The modality-based segments of the medical imaging market are magnetic resonance imaging (MRI), x-ray systems, ultrasound systems, and nuclear imaging, and computed tomography (CT). The application-based segments of the global medical imaging market are cardiology, neurology, and oncology among others. The end-user-based segments of the medical imaging market are hospitals and clinics, academic institutes, diagnostic centers, and research organizations.

Imaging systems play pivotal role in diagnosis, and subsequent designing of correct and effective prognosis regimen. The increasing need for medical imaging systems in diagnosis, choice of treatment, and monitoring progress, is resulting in strategic joint ventures between reputed players to generate decent revenue. In addition, hike in research and development undertakings for advancements in imaging devices and growing awareness about new diagnostics solutions to detect fatal disease at early stage are creating scopes for emerging players to capitalize, for generating decent resources. Lack of trained professionals and financial strap on healthcare organizations are some issues hindering sales of medical imaging systems.

 

Regional Analysis

The Americas, Europe, Middle East and Africa, and Asia-Pacific are regions that are assessed under the geographic analysis of the medical imaging market. As per MRFR study, the Americas medical imaging market can dominant the global market in review tenure. The presence of numerous medical imaging system suppliers and growing prevalence of chronic diseases can prompt the regional market in the review period. The surge in funding by medical and technical organizations for research can benefit the market in the coming period. The rise in number of diagnostic tests and increase in research undertaking on cancer can bolster the regional medical imaging market growth.

In Europe, the medical imaging market is expected to earn decent value through the forecast term due to the presence of different favorable government laws and initiatives. The existence of a large population base suffering from lifestyle-associated conditions, and high rate of adoption imaging devices are other causes that can influence Europe medical imaging market in the approaching years.

In Asia Pacific, the medical imaging market can expand at high CAGR across the study tenure 2019 to 2025. Increase in capita health spending, developing healthcare sector across India, and Australia, growing older population base, and the presence a robust regulatory framework that aid in accelerated diagnostic process and product approvals at comparatively lower prices are some of the crucial factors that are identified to support APAC medical imaging market by 2025.

In the Middle East and Africa, the medical imaging market can rise at a modest pace from 2019 to 2025. The medical imaging market in Middle East can hold considerable market share through the assessment period. The developing medical infrastructure and surge in cases of medical tourism are causes that can earn profit for the medical device industry.

 

Key Players

Market Research Future (MRFR) recognizes some of the top-notch players in the medical imaging market. They are; Esaote S.p.A (Italy), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd (Japan), FUJIFILM Holdings Corporation (Japan), Medtronic PLC (Ireland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Analogic Corporation (US), Koninklijke Philips N.V., Siemens AG (Germany), Hologic, Inc. (US), Samsung (South Korea), Shimadzu Corporation (Japan), Carestream Health (US), CMR Naviscan (US), Canon Medical Systems Corporation (Japan), and General Electric Company (US),

Read more @ https://www.marketresearchfuture.com/reports/medical-imaging-market-1995

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Hormonal Implants Market 2021: COVID-19 Impact Sales Revenue, Development Strategy, Growth Potential, Analysis and Business Distribution

 Market Highlights

The Global Hormonal Implants Market is estimated to have a positive growth at the CAGR of ~5.0% during the forecast period of 2019–2025.

A study observed that no pregnancy was observed in a group of certain women using hormonal implants for five years. Safety from unwanted pregnancies and suitable government programmers are the major factors driving the market growth.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8242    

However, cases of side-effects related to hormonal contraceptives, pricing variations, and limited availability of the product are restraining the growth of the market during the assessment period is hindering the growth of the global hormonal implants market in the forecast period.

Global, as well as local players, are present in the hormonal implants market. A majority of the market is currently held by global players like Allergan. In May 2016, ALLERGAN took an initiative to help the US military servicewomen to access LILETTA under the Federal Supply Schedule (FSS) price of USD 55.83 to educate these servicewomen about the importance of contraception.

Regional Analysis

The global hormonal implants market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hormonal implants market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European hormonal implants market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been segmented as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hormonal implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hormonal implants market in the Middle East & Africa has been divided into the Middle East and Africa. 

Key Players

Some of the key players in the global hormonal implants market are Shanghai Dahua Pharmaceuticals Co., Merck & Co., Inc., Bayer HealthCare, Ltd and Allergan.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/hormonal-implants-market-8242 

Segmental Analysis

The global hormonal implants market has been segmented based hormone, type, distribution sector, end user, and region.

The market, based on hormone, has been bifurcated into levonorgestrel and etonogestrel. The levonorgestrel segment is anticipated to hold the largest share in the market, market due to the wider preferability and longer durability compared to other contraceptives for the use of hormonal implants.

The market, based on the distribution sector, has been segmented into the public sector and private sector. The public sector market is expected to hold the largest share in the market, due to increasing adoption rates in public healthcare facilities under various government regulations.

The market, by end-user, has been divided into hospitals & clinics, academic & research institutes. The hospitals & clinics segment is expected to lead the market, due to the major commercialization is done through them.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Veterinary Imaging Market Growth Is Driven By The Increasing Demands of Various Therapies and Geographical Regions

 Market Insights:

The evolvement of pet insurance has made vet fees affordable which has propelled the demand for advanced diagnosis and veterinary imaging tests. Market Research Future (MRFR) has asserted in its latest report that the global veterinary imaging market will expand throughout the forecast period 2017 to 2023 at 6.9% CAGR. The global market was valued at USD 1.24 Bn in 2017 and is projected to reach a valuation of USD 1.85 Bn by the end of 2023.

The growth in the rate of pet adoption backed by reimbursement schemes of insurance policies has fueled the market for veterinary imaging. The increased research and development activities undertaken by the key players for introducing innovation in the market has multiplied the revenue generation from the market. Furthermore, the rising prevalence of zoonotic diseases has fostered a need for improved diagnosis for the animals which has favored the market expansion of veterinary imaging. However, the cost associated with veterinary imaging is high if insurance reimbursement is not availed of, which might restrict the growth of the market during the assessment period.

Global Veterinary Imaging Market Segmentation:

By type, the global veterinary imaging market has been segmented into veterinary imaging instruments, veterinary imaging reagents, and veterinary imaging software.

By product type, the market for veterinary imaging is segmented into large animals, small companion animals, and others.

By therapeutic area, the global veterinary imaging market has been segmented into orthopedics and traumatology, cardiology, neurology, and, oncology.

By end-user, the market for veterinary imaging market is segmented into hospitals & clinics, and, academic institute.

Regional Analysis:

By region, the global veterinary imaging market has been segmented into Americas, Europe, Asia Pacific, and, Middle East & Africa. The Americas market accounts for the most substantial share of the market revenue and is expected to continue exercising its dominance over the assessment period. The Americas market is further sub-segmented into North America and South America with North America leading the growth in the region. According to the American Pet Products Association 2015-2016 (APPA), 85.8 million cats and 78 million dogs were owned in the U.S. alone. The growth in Americas can be attributed to the evolution in the pet healthcare sector. The key driver of the market in this region is the pet insurance and reimbursement policy which has fueled the growth of the veterinary imaging market.

Europe market has been witnessing a gradual increase in the rate of pet adoption which has fueled the demand for veterinary imaging market in the region and is expected to grow persistently over the next couple of years. The Europe market is likely to thrive throughout the projection period with major contributions coming from developed economies such as Germany, France, and, the U.K. Asia Pacific is projected to be one of the largest markets by 2023 with the highest CAGR across the projection period. With the rising pet ownership in the region, the expenditure on pet healthcare is also on a rise which has affirmed the growth of the market over the assessment period. The countries such as India, China, and, Japan will be the primary hub of revenue generation in Asia Pacific market.

Competitive Dashboard:

The key players profiled by MRFR in its report for detailed analysis of the market include Fujifilm Holding Corporation, Idexx Laboratory Inc, BCF Technology, Ltd, Medical Imaging / IMCO, Inc, Merry X-Ray, Carestream Health, General Electric, Heska Corporation, Canon Inc, Esaote SpA, Diagnostic Imaging System, Inc, and, Hallmarq Veterinary Imaging Ltd. The players are striving to gain prominence in the market and strengthen their footholds by implementing strategies such as acquisitions & mergers, expansion of product portfolios, research & development activities, technical advancements, etc.

CGS Hospital, Gurugram (India), is all set for the deployment of Computed Tomography (CT) scanner for pets to make surgical approach easier. According to the hospital authorities, the scanner will be first of its kind in the country and is estimated to cost around USD 20 Mn. Presently, the hospital uses scanners designed for humans to treat the pets. With the deployment of the new CT scanner for pets, the hospital will be better positioned to deal with canine and feline tumors, cancers, and other injuries.

Venous blood collection devices are used to collect sample from patients. Venous blood collection devices include needles, holders, collection tubes, and other devices. As per an in-depth research study published by Market Research Future (MRFR), the global venous blood collection devices market is estimated to post a CAGR of 9.3% over the forecast period of 2017-2023. 

Substantial improvements made by medical device manufacturers towards safer blood collection. Advances in safety features and greater emphasis on the prevention of injury and reduction of bloodborne pathogen exposure fuel the growth of the global venous blood collection devices market. Moreover, medical device manufacturers are endeavoring towards product improvement and are diversifying their product portfolios as a growth strategy which also acts as a plus for the growth of the market. Crucial advancements include the introduction of plastic tubes, protective sliding needle shields, automatically retracting lancets, and winged-needle blood collection sets. 

Chronic diseases are spreading at a brisk pace which has exerted massive burden on the healthcare sector. Screening for diseases induces high demand for diagnostic services which, in turn, triggers growth within the global venous blood collection devices market. Other factors which can accelerate the market growth include surging health & wellness awareness among the global populace, the rise in disposable income, and high healthcare expenditure. 

On the flip side, venous blood collection devices are associated with the risk of needlestick injuries, contamination risks which can restrict the market growth. Additionally, pricing pressure on medical device manufacturers and substandard products from local medical device manufacturers can also undermine the growth of the market. 

 Venous Blood Collection Devices Market Segmentation

The global venous blood collection devices market has been segmented based on type, material, application, and end user.

By type, the global venous blood collection devices market has been segmented into blood collection tubes, needles, microfluidic system, vacuum blood collection system, micro-container tubes, micro-hematocrit tubes, warming devices, and others. Other venous blood collection devices include venous cannula and blood bags. The blood collection tube segment has been further segmented into plasma separation tube, heparin tube, serum separating tube, EDTA tube, and others.

By material, the global blood collection devices market has been segmented into plastic, glass, stainless steel, ceramic, and others.

By application, the global venous blood collection devices market has been segmented into vein blood gas sampling and intraoperative blood salvage. The vein blood gas sampling segment has been further segmented into diagnosis of disease and acid-base status monitoring.

By end user, the global venous blood collection devices market has been segmented into hospitals and clinics, blood donation centers, the point of care, diagnostic centers, and others.

Venous Blood Collection Devices Market Regional Analysis

By region, the global venous blood collection devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). 

The Americas is spearheading the global venous blood collection devices market. Rapid adoption of new surgical techniques and instruments within the healthcare sector in the region are substantiating the growth of the market. High demand for screening services coupled with high healthcare expenditure is driving the market growth. Moreover, greater awareness among consumers and favorable reimbursement landscape support the growth of the market. 

Europe ranks second in the global venous blood collection devices market. High-income population and deep healthcare penetration in the region are favoring the growth of the market in Europe.

The expanding healthcare sector in the developing countries such as China and India generate high demand for venous blood collection devices in APAC. The rise in the geriatric population, the prevalence of chronic diseases which require screening services and increased demand for advanced blood sampling techniques are propelling the growth of the APAC venous blood collection devices market.

The MEA market is estimated to expand at a steady pace over the forecast period. Accelerated development of the healthcare sector and awareness programs launched by the government towards safe blood transfusion procedures are triggering growth within the MEA market. 

Competitive Landscape

The key players in the global venous blood collection devices market include SanLI (Myanmar.), KHB (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Bio-Rad Laboratories, Inc. (U.S), Kabe Labortechnik GmbH (Germany), NIPRO Medical Corporation (Japan), Qiagen NV (Netherlands), Sarstedt AG & Co (U.S.), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Greiner Bio One International GmbH (Greiner Group) (Austria), Becton, Dickinson and Company (U.S), Terumo Medical Corporation (Japan), Medtronic Plc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), Improve Medical Technology Co. Ltd. (U.S.), Sekisui Chemical Co., Ltd. (Japan), Hongyu Medical (China), Narang Medical (India), Vital Diagnostice (ELITech Group) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), CDRICH (China), Biosigma (U.S.), Soya Green Tec Co., Ltd. (South Korea), and F.L. Medical (Italy). 

Industry Updates

March 2019- Becton Dickinson & Co., a medical technology company, announced that the US FDA had granted pre-market approval for its new Venovo stent. The new device is ideally suited for the treatment of iliofemoral occlusive disease and specially designed to address the challenges associated with venous lesions. 

Read More @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Venous Blood Collection Devices Market Industry Size, Growth Opportunities, Competitive Analysis and Forecast to 2027

 Venous blood collection devices are used to collect sample from patients. Venous blood collection devices include needles, holders, collection tubes, and other devices. As per an in-depth research study published by Market Research Future (MRFR), the global venous blood collection devices market is estimated to post a CAGR of 9.3% over the forecast period of 2017-2023. 

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5761 

Substantial improvements made by medical device manufacturers towards safer blood collection. Advances in safety features and greater emphasis on the prevention of injury and reduction of bloodborne pathogen exposure fuel the growth of the global venous blood collection devices market. Moreover, medical device manufacturers are endeavoring towards product improvement and are diversifying their product portfolios as a growth strategy which also acts as a plus for the growth of the market. Crucial advancements include the introduction of plastic tubes, protective sliding needle shields, automatically retracting lancets, and winged-needle blood collection sets. 

Chronic diseases are spreading at a brisk pace which has exerted massive burden on the healthcare sector. Screening for diseases induces high demand for diagnostic services which, in turn, triggers growth within the global venous blood collection devices market. Other factors which can accelerate the market growth include surging health & wellness awareness among the global populace, the rise in disposable income, and high healthcare expenditure. 

On the flip side, venous blood collection devices are associated with the risk of needlestick injuries, contamination risks which can restrict the market growth. Additionally, pricing pressure on medical device manufacturers and substandard products from local medical device manufacturers can also undermine the growth of the market. 

 Venous Blood Collection Devices Market Segmentation

The global venous blood collection devices market has been segmented based on type, material, application, and end user.

By type, the global venous blood collection devices market has been segmented into blood collection tubes, needles, microfluidic system, vacuum blood collection system, micro-container tubes, micro-hematocrit tubes, warming devices, and others. Other venous blood collection devices include venous cannula and blood bags. The blood collection tube segment has been further segmented into plasma separation tube, heparin tube, serum separating tube, EDTA tube, and others.

By material, the global blood collection devices market has been segmented into plastic, glass, stainless steel, ceramic, and others.

By application, the global venous blood collection devices market has been segmented into vein blood gas sampling and intraoperative blood salvage. The vein blood gas sampling segment has been further segmented into diagnosis of disease and acid-base status monitoring.

By end user, the global venous blood collection devices market has been segmented into hospitals and clinics, blood donation centers, the point of care, diagnostic centers, and others.

Venous Blood Collection Devices Market Regional Analysis

By region, the global venous blood collection devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). 

The Americas is spearheading the global venous blood collection devices market. Rapid adoption of new surgical techniques and instruments within the healthcare sector in the region are substantiating the growth of the market. High demand for screening services coupled with high healthcare expenditure is driving the market growth. Moreover, greater awareness among consumers and favorable reimbursement landscape support the growth of the market. 

Europe ranks second in the global venous blood collection devices market. High-income population and deep healthcare penetration in the region are favoring the growth of the market in Europe.

The expanding healthcare sector in the developing countries such as China and India generate high demand for venous blood collection devices in APAC. The rise in the geriatric population, the prevalence of chronic diseases which require screening services and increased demand for advanced blood sampling techniques are propelling the growth of the APAC venous blood collection devices market.

The MEA market is estimated to expand at a steady pace over the forecast period. Accelerated development of the healthcare sector and awareness programs launched by the government towards safe blood transfusion procedures are triggering growth within the MEA market. 

Competitive Landscape

The key players in the global venous blood collection devices market include SanLI (Myanmar.), KHB (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Bio-Rad Laboratories, Inc. (U.S), Kabe Labortechnik GmbH (Germany), NIPRO Medical Corporation (Japan), Qiagen NV (Netherlands), Sarstedt AG & Co (U.S.), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Greiner Bio One International GmbH (Greiner Group) (Austria), Becton, Dickinson and Company (U.S), Terumo Medical Corporation (Japan), Medtronic Plc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), Improve Medical Technology Co. Ltd. (U.S.), Sekisui Chemical Co., Ltd. (Japan), Hongyu Medical (China), Narang Medical (India), Vital Diagnostice (ELITech Group) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), CDRICH (China), Biosigma (U.S.), Soya Green Tec Co., Ltd. (South Korea), and F.L. Medical (Italy). 

Industry Updates

March 2019- Becton Dickinson & Co., a medical technology company, announced that the US FDA had granted pre-market approval for its new Venovo stent. The new device is ideally suited for the treatment of iliofemoral occlusive disease and specially designed to address the challenges associated with venous lesions. 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Diabetic Retinopathy Market Research Based on COVID 19 and Analysis on Techniques and Applications Report 2020-2027

 Diabetic Retinopathy Market

Market Highlights

Diabetic retinopathy is an eye disease among the diabetic patients. It is of two types, namely, non-proliferative diabetic retinopathy and proliferative advanced diabetic retinopathy. Non-proliferative diabetic retinopathy is the early stage of the disease in which the blood vessels in the retina are weakened. Proliferative diabetic retinopathy is the advanced type of the disease in which the retina is deprived of oxygen due to circulation problems. Diabetic retinopathy can be diagnosed using tests such as fluorescein angiography and optical coherence tomography. The treatment involves the use of intraocular steroid injection, laser treatment, anti-VEGF therapy, vitrectomy, and others.

The market for diabetic retinopathy exhibits a potential growth with an increasing prevalence of diabetes and increasing awareness about diabetes management. Additionally, the huge demand for diagnostic tests for diabetic retinopathy also accelerates the growth of the market. The global diabetic retinopathy market is expected to grow at a CAGR of 5.2% during the forecast period.

Some of the key players in the global market are Novartis AG (Germany), Bayer (Germany), Regeneron Pharmaceuticals Inc. (U.S.), ThromboGenics (U.S.), Actavis Plc (U.K.), Sirnaomics(U.S.), Genentech (U.S.), Alimera Sciences (U.S.), Glycadia Pharmaceuticals (U.S.), Ampio Pharmaceuticals (U.S.), Kowa Group (Japan), BCN Peptides (Spain), and others.

Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (ToC) & market synopsis on the “Diabetic Retinopathy Market Research Report–Global forecast till 2023.”

Access Report Details @ https://www.marketresearchfuture.com/reports/diabetic-retinopathy-market-5792 

Regional Analysis

America is the largest market for diabetic retinopathy market size with an increase in the number of specialty care centers for diabetes management and availability of diagnostic and treatment services in the market. In North America, the U.S. is the market which is driven by the presence of key players in the market and increasing focus on preventive care for various chronic diseases such as diabetes, obesity, and others.

In Europe, factors determining the growth of the market are increasing the prevalence of diabetes and emphasis on continuous health monitoring and early diagnosis. Furthermore, on-going research activities are also expected to boost the market growth during the forecast period.

In Asia Pacific, the diabetic retinopathy market is expected to exhibit an upright growth in the coming future. The market growth is driven by the rising geriatric population, huge patient population, and increasing demand for treatment services for diabetes. China harbors a huge geriatric population, thereby increasing the risk of various chronic diseases such as diabetes, cardiovascular diseases, and others.

The market in the Middle East and Africa is driven by the increasing number of specialty care services in countries such as the United Arab Emirates and Saudi Arabia and the growth of the healthcare industry. In Africa, the prevalence of non-communicable diseases is found to be increasing, thereby accelerating the growth of the market.

Segmentation

The global diabetic retinopathy market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into non-proliferative diabetic retinopathy and proliferative advanced diabetic retinopathy.

On the basis of diagnosis, the market is segmented into fluorescein angiography and optical coherence tomography.

On the basis of treatment, the market is segmented into laser treatment, anti-VEGF therapy, vitrectomy, and others. The laser treatment is further segmented into focal laser treatment and scatter laser treatment.

On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, research institutes, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Venous Blood Collection Devices Market Dynamics, Comprehensive Analysis, Business Growth, Revealing Key Drivers, Prospects and Opportunities 2027

Venous blood collection devices are used to collect sample from patients. Venous blood collection devices include needles, holders, collection tubes, and other devices. As per an in-depth research study published by Market Research Future (MRFR), the global venous blood collection devices market is estimated to post a CAGR of 9.3% over the forecast period of 2017-2023. 

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5761 

Substantial improvements made by medical device manufacturers towards safer blood collection. Advances in safety features and greater emphasis on the prevention of injury and reduction of bloodborne pathogen exposure fuel the growth of the global venous blood collection devices market. Moreover, medical device manufacturers are endeavoring towards product improvement and are diversifying their product portfolios as a growth strategy which also acts as a plus for the growth of the market. Crucial advancements include the introduction of plastic tubes, protective sliding needle shields, automatically retracting lancets, and winged-needle blood collection sets. 

Chronic diseases are spreading at a brisk pace which has exerted massive burden on the healthcare sector. Screening for diseases induces high demand for diagnostic services which, in turn, triggers growth within the global venous blood collection devices market. Other factors which can accelerate the market growth include surging health & wellness awareness among the global populace, the rise in disposable income, and high healthcare expenditure. 

On the flip side, venous blood collection devices are associated with the risk of needlestick injuries, contamination risks which can restrict the market growth. Additionally, pricing pressure on medical device manufacturers and substandard products from local medical device manufacturers can also undermine the growth of the market. 

Venous Blood Collection Devices Market Segmentation

The global venous blood collection devices market has been segmented based on type, material, application, and end user.

By type, the global venous blood collection devices market has been segmented into blood collection tubes, needles, microfluidic system, vacuum blood collection system, micro-container tubes, micro-hematocrit tubes, warming devices, and others. Other venous blood collection devices include venous cannula and blood bags. The blood collection tube segment has been further segmented into plasma separation tube, heparin tube, serum separating tube, EDTA tube, and others.

By material, the global blood collection devices market has been segmented into plastic, glass, stainless steel, ceramic, and others.

By application, the global venous blood collection devices market has been segmented into vein blood gas sampling and intraoperative blood salvage. The vein blood gas sampling segment has been further segmented into diagnosis of disease and acid-base status monitoring.

By end user, the global venous blood collection devices market has been segmented into hospitals and clinics, blood donation centers, the point of care, diagnostic centers, and others.

Venous Blood Collection Devices Market Regional Analysis

By region, the global venous blood collection devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). 

The Americas is spearheading the global venous blood collection devices market. Rapid adoption of new surgical techniques and instruments within the healthcare sector in the region are substantiating the growth of the market. High demand for screening services coupled with high healthcare expenditure is driving the market growth. Moreover, greater awareness among consumers and favorable reimbursement landscape support the growth of the market. 

Europe ranks second in the global venous blood collection devices market. High-income population and deep healthcare penetration in the region are favoring the growth of the market in Europe.

The expanding healthcare sector in the developing countries such as China and India generate high demand for venous blood collection devices in APAC. The rise in the geriatric population, the prevalence of chronic diseases which require screening services and increased demand for advanced blood sampling techniques are propelling the growth of the APAC venous blood collection devices market.

The MEA market is estimated to expand at a steady pace over the forecast period. Accelerated development of the healthcare sector and awareness programs launched by the government towards safe blood transfusion procedures are triggering growth within the MEA market. 

Competitive Landscape

The key players in the global venous blood collection devices market Size include SanLI (Myanmar.), KHB (U.S.), Allegro Medical Supplies Inc. (Scrip Products Corporation) (U.S.), Bio-Rad Laboratories, Inc. (U.S), Kabe Labortechnik GmbH (Germany), NIPRO Medical Corporation (Japan), Qiagen NV (Netherlands), Sarstedt AG & Co (U.S.), Fisher Scientific (Thermo Fisher Scientific Inc.) (U.S.), Greiner Bio One International GmbH (Greiner Group) (Austria), Becton, Dickinson and Company (U.S), Terumo Medical Corporation (Japan), Medtronic Plc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Radiometer Medical ApS (Danaher Corporation/ Danrad ApS) (Denmark), Improve Medical Technology Co. Ltd. (U.S.), Sekisui Chemical Co., Ltd. (Japan), Hongyu Medical (China), Narang Medical (India), Vital Diagnostice (ELITech Group) (U.S.), Zhejiang Gongdong Medical Technology Co., Ltd. (China), CDRICH (China), Biosigma (U.S.), Soya Green Tec Co., Ltd. (South Korea), and F.L. Medical (Italy). 

Industry Updates

March 2019- Becton Dickinson & Co., a medical technology company, announced that the US FDA had granted pre-market approval for its new Venovo stent. The new device is ideally suited for the treatment of iliofemoral occlusive disease and specially designed to address the challenges associated with venous lesions. 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Medical Imaging Market Trend, Latest News, Business Demand, Research Study and Forecast to 2025

 Overview:

The global medical imaging market is showing a great possibility of reaching USD 45,719.65 million by 2025, with a CAGR of 6.52% during the forecast period of 2019 to 2025. Market Research Future (MRFR) reveals factors that can be effective in taking the global market ahead.

These factors are the hike in diagnosis process to determine better treatment routes at an early stage, better inclusion rate of latest products, hike in investment to boost research and development sector, growing demand from developing countries where the healthcare sector is getting revamped, increasing competition among players to develop better products and edge out others, government initiatives, and others. These can contribute to the development of strategies and increase the revenues for the market. 

However, the price of these products is high, which might restrain the market in poor economies. 

Segmentation:

The global medical imaging market share has been studied by MRFR experts on the basis of application, modality, and end user. The market report has revealed several growth-inducing factors that can help in developing strategies that will be backed by various factors and figures. 

By modality, the global study of the medical imaging market is getting backed by segments like magnetic resonance imaging (MRI), computed tomography (CT), ultrasound systems, x-ray systems, and nuclear imaging. 

By application, the global report on the medical imaging market has been segmented on the basis of oncology, neurology, cardiology, and others. Demand for better diagnostic support from all these industries has boosted the growth of the market.

By end user, the global study on the medical imaging market depends on the segmentation that includes diagnostic centers, academic institutes, hospitals and clinics, and research organizations. The hospitals & clinics segment would score well due to their superlative infrastructures. 

Regional Analysis:

North America would dominate the global market in terms of generating revenues as countries like the US and Canada are pushing the market forward by increasing their investment. In Europe, the same is happening with countries like France, Germany, the UK, Italy, and others boosting the regional market. In Asia Pacific, Japan, China, India, and others are making the most of the contribution. 

Competitive Landscape:

The global market for medical imaging is benefiting from the strategic routes adopted by companies like Canon Medical Systems Corporation (Japan), Carestream Health (US), Siemens AG (Germany), Analogic Corporation (US), General Electric Company (US), Esaote S.p.A (Italy), CMR Naviscan (US), Hologic, Inc. (US), Medtronic PLC (Ireland), FUJIFILM Holdings Corporation (Japan), Hitachi Ltd (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Samsung (South Korea), Koninklijke Philips N.V., Shimadzu Corporation (Japan), and others. These companies have strategies that encompass mergers, acquisitions, collaborations, product launching, innovations, better investment policies for research and development, and others as major growth-inducing factors. MRFR records the changes in the global market to know how the market may chart the course to stay abreast and profit in the coming years. 

Industry News:

Cerebriu, a Danish medical technology provider, recently announced the launch of their Cerebriu Apollo. This technology is a software solution aimed at providing clinical support using accelerated and personalized diagnostic medical imaging. It gets backing from the machine learning that helps in reading MRI images after their scanning is done and detects potential issues like a tumor or signs of a stroke. Once it identifies the issue, it notifies the practitioner who can then treat the patient on the basis of needed protocols and other things. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/